Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial (vol 1, pg e60, 2014)

被引：0
|
作者：
Sierra-Madero, J. G.
Ellenberg, S. S.
Rassool, M. S.
机构：
来源：
LANCET HIV | 2015年 / 2卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E416 / E416
页数：1
相关论文
共 50 条
  • [1] Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial
    Sierra-Madero, Juan G.
    Ellenberg, Susan S.
    Rassool, Mohammed S.
    Tierney, Ann
    Belaunzaran-Zamudio, Pablo F.
    Lopez-Martinez, Alondra
    Pineirua-Menendez, Alicia
    Montaner, Luis J.
    Azzoni, Livio
    Rivera Benitez, Cesar
    Sereti, Irini
    Andrade-Villanueva, Jaime
    Mosqueda-Gomez, Juan L.
    Rodriguez, Benigno
    Sanne, Ian
    Lederman, Michael M.
    LANCET HIV, 2014, 1 (02): : E60 - E67
  • [2] CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial
    van Kuijk, Arno W. R.
    Vergunst, Clarissa E.
    Gerlag, Danielle M.
    Bresnihan, Barry
    Gomez-Reino, Juan J.
    Rouzier, Regine
    Verschueren, Patrick C.
    van de Leij, Christiaan
    Maas, Mario
    Kraan, Maarten C.
    Tak, Paul P.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (11) : 2013 - 2016
  • [3] CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial (vol 69, pg 2013, 2010)
    van Kuijk, A. W. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) : 630 - 630
  • [4] No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial
    Carr, A
    Workman, C
    Carey, D
    Rogers, G
    Martin, A
    Baker, D
    Wand, H
    Law, M
    Samaras, K
    Emery, S
    Cooper, DA
    LANCET, 2004, 363 (9407): : 429 - 438
  • [5] Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial (vol 5, pg e553, 2018)
    LANCET HIV, 2019, 6 (12): : E815 - E815
  • [6] Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial (vol 15, pg 966, 2014)
    van Rhee, F.
    Wong, R. S.
    Munshi, N.
    LANCET ONCOLOGY, 2014, 15 (10): : E417 - E417
  • [7] A Double-Blind, Placebo-Controlled Trial of Maraviroc in Treatment-Experienced Patients Infected with Non-R5 HIV-1
    Saag, Michael
    Goodrich, James
    Faetkenheuer, Gerd
    Clotet, Bonaventura
    Clumeck, Nathan
    Sullivan, John
    Westby, Mike
    van der Ryst, Elna
    Mayer, Howard
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (11): : 1638 - 1647
  • [8] Antiobesity effect of Gynostemma pentaphyllum Extract (Actiponin): A Randomized, Double-Blind, Placebo-Controlled Trial (vol 22, pg 63, 2014)
    Park, Soo-Hyun
    Huh, Tae-Lin
    Kim, Sun-Young
    Oh, Mi-Ra
    Pichiah, P. B. Tirupathi
    Chae, Soo-Wan
    Cha, Youn-Soo
    OBESITY, 2020, 28 (09) : 1770 - 1773
  • [9] Antiobesity Effect of Gynostemma pentaphyllum Extract (Actiponin): A Randomized, Double-Blind, Placebo-Controlled Trial (vol 22, pg 63, 2014)
    Park, Soo-Hyun
    Huh, Tae-Lin
    Kim, Sun-Young
    Oh, Mi-Ra
    Pichiah, P. B. Tirupathi
    Chae, Soo-Wan
    Cha, Youn-Soo
    OBESITY, 2015, 23 (12) : 2520 - 2520
  • [10] Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome (vol 172, pg 485, 1998)
    Wearden, AJ
    Morriss, RK
    Mullis, R
    Strickland, PL
    Pearson, DJ
    Appleby, L
    Campbell, IT
    Morris, JA
    BRITISH JOURNAL OF PSYCHIATRY, 1998, 173 : 89 - 89
12345